SCRS Welcomes Greenphire as a Global Impact Partner
Strategic collaboration brings like-minded experts together to support site sustainability
Ellicott City, MD â The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced that Greenphire, the global leader in clinical payment solutions, has joined its Global Impact Partner (GIP) program. As a GIP, Greenphire will participate on the SCRS Global Impact Board at an executive level and work closely with its Leadership Council to determine strategic initiatives. “Site sustainability and success is the core focus of our business,” said Jim Murphy, Greenphire CEO. “We are excited to join this program and collaborate with other industry leaders on how to further empower research sites around the world to optimize processes and improve the clinical trial experience for all involved.” Greenphire kicked off their involvement by joining the SCRS Site Payments Initiative meeting on May 17th. The purpose of this initiative is to establish an industry standard for the frequency and process of how sites receive payments for work conducted related to industry sponsored clinical research. “Greenphire continues to demonstrate a strong commitment to supporting SCRS and our efforts to bringing the site voice to the payment process,” said Christine Pierre, President of SCRS. “We are excited to include the expert Greenphire team in our GIP program, as it will support our effort to providing a unified voice of the global clinical research site community for greater site sustainability.”
About SCRS
SCRS is a global trade organization founded in 2012 which represents over 2,800 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Visit
MySCRS.org
.
About Greenphire
Greenphire is the leader in global clinical trial payment solutions. Greenphire’s best-in-class solutions optimize clinical trial performance by simplifying and streamlining payment processes from sponsors and CROs to sites and patients. Greenphire’s ClinCard and eClinicalGPS solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. Learn more at
www.greenphire.com
.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
